MyFinsight
Home
Blog
About
Contact
cnta: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$12,340K
(-22.32%↓ Y/Y)
Tax incentive
receivable
$49,121K
(44.35%↑ Y/Y)
Short-term investments
$195,403K
(58.32%↑ Y/Y)
Cash and cash
equivalents
$50,811K
(-87.14%↓ Y/Y)
Other non-current
assets
$1,589K
(-28.78%↓ Y/Y)
Deferred tax asset
$25,022K
(-7.51%↓ Y/Y)
Operating lease
right-of-use assets
$10,295K
(-8.44%↓ Y/Y)
Property and equipment,
net
$894K
(8.89%↑ Y/Y)
Long-term investments
$102,825K
Total current assets
$307,675K
(-45.87%↓ Y/Y)
Total assets
$448,300K
(-26.47%↓ Y/Y)
Total liabilities and
shareholders' equity
$448,300K
(-26.47%↓ Y/Y)
Total shareholders
equity
$301,574K
(-39.58%↓ Y/Y)
Total liabilities
$146,726K
(32.69%↑ Y/Y)
Accumulated deficit
-$1,120,071K
(-27.66%↓ Y/Y)
Accumulated other
comprehensive income
$2,600K
(24.11%↑ Y/Y)
Additional paid-in capital
$1,418,681K
(3.25%↑ Y/Y)
Other non-current
liabilities
$29K
(0.00%↑ Y/Y)
Operating lease
liabilities
$7,759K
(-8.10%↓ Y/Y)
Long term debt
$109,816K
(45.07%↑ Y/Y)
Total current
liabilities
$29,122K
(10.29%↑ Y/Y)
Ordinary shares 0.002
nominal...
$364K
(1.96%↑ Y/Y)
Accrued expenses and
other current...
$20,439K
(7.78%↑ Y/Y)
Accounts payable
$8,683K
(16.66%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)